Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 5

Results: 9

Opinion Mining of Erowid's Experience Reports on LSD and Psilocybin-Containing Mushrooms: Opinion Mining of Erowid's Psychedelic Reports: A. Al-Imam et al.

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 559, doi. 10.1007/s40264-025-01530-z

By:

Al-Imam, Ahmed;
Lora, Riccardo;
Motyka, Marek A.;
Marletta, Erica;
Vezzaro, Michele;
Moczko, Jerzy;
Younus, Manal;
Michalak, Michal

Publication type:

Article

A Longitudinal Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: A Cohort Study in Denmark and Sweden, 2013–2021: Post-authorization Safety Study of Golimumab in Treatment of Ulcerative Colitis: Cohort Study in Denmark and Sweden: A. K. Ersbøll et al

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 541, doi. 10.1007/s40264-025-01519-8

By:

Ersbøll, Annette Kjær;
Huang, Zhiping;
Hill, Deanna D.;
Hede, Simone Møller;
Andersen, Vibeke;
Bolin, Kristian;
Kristensen, Marie Skov;
Esslinger, Suzan;
Hansen, Frida Richter;
Hertervig, Erik;
Kallio, Lila;
Kjærulff, Thora Majlund;
Kloster, Stine;
Krumme, Alexis;
Lewis, James D.;
Mehkri, Laila;
Qvist, Niels;
Thygesen, Lau Caspar;
Weinstein, Cindy;
Green, Anders

Publication type:

Article

Assessment of Pharmacovigilance Across University Hospitals in Morocco: Assessment of Pharmacovigilance Across University Hospitals in Morocco: H. Hamzaoui et al.

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 527, doi. 10.1007/s40264-025-01517-w

By:

Hamzaoui, Hind;
Shaum, Anna;
Cherkaoui, Imad;
Moussa, Latifa Ait;
Sefiani, Houda;
Talibi, Ismail;
Benabdallah, Ghita;
Salman, Omar;
Ferrey, Seth;
Soulaymani Bencheikh, Rachida

Publication type:

Article

Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study Based on Japanese Health Insurance Claims Data: Risk of Fracture Associated with Pregabalin or Mirogabalin Use: H. Wakabayashi et al.

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 503, doi. 10.1007/s40264-025-01516-x

By:

Wakabayashi, Hinako;
Fukasawa, Toshiki;
Yoshida, Satomi;
Ri, Kairi;
Masuda, Soichiro;
Anno, Takayuki;
Kawakami, Koji

Publication type:

Article

Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction: Network Analysis and Machine Learning for Signal Detection Using Electronic Healthcare Records: M. A. Barbieri et al

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 513, doi. 10.1007/s40264-025-01515-y

By:

Barbieri, Maria Antonietta;
Abate, Andrea;
Balogh, Olivér M.;
Pétervári, Mátyás;
Ferdinandy, Péter;
Ágg, Bence;
Battini, Vera;
Cocco, Marianna;
Rossi, Andrea;
Carnovale, Carla;
Casula, Manuela;
Spina, Edoardo;
Sessa, Maurizio

Publication type:

Article

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference: Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: V. Bauchau et al

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 577, doi. 10.1007/s40264-024-01510-9

By:

Bauchau, Vincent;
Bollaerts, Kaatje;
Bryan, Phil;
Buttery, Jim;
Davis, Kourtney;
Chen, Robert T.;
Feikin, Daniel R.;
Fretta, Antonella;
Frise, Sarah;
Gandhi-Banga, Sonja;
Izurieta, Hector S.;
Jouquelet-Royer, Corinne;
Khromava, Alena;
Li, Lin;
Long, Raj;
MacDonald, Sarah;
Marcelon, Lydie;
Massouh, Robert;
Meeraus, Wilhelmine;
Munoz, Flor M.

Publication type:

Article

Emerging Tools to Support DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases: DILI Assessment in Clinical Trials with Abnormal Baseline Serum Liver Tests or Pre-existing Liver Diseases: J. Amirzadegan et al

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 443, doi. 10.1007/s40264-024-01511-8

By:

Amirzadegan, Jasmine;
Tesfaldet, Bereket;
Pei, Y. Veronica;
Navarro Almario, Eileen;
Avigan, Mark I.;
Hayashi, Paul H.

Publication type:

Article

Sequential Epidemiological Analyses of Real-World Data: A Tool for Prospective Drug Safety Surveillance from the Rofecoxib Example: Sequential Epidemiological Analyses of Real-World Data: S. H. Abbasi et al.

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 489, doi. 10.1007/s40264-024-01512-7

By:

Abbasi, Saad Hanif;
Lund, Lars Christian;
Hallas, Jesper;
Pottegård, Anton

Publication type:

Article

Drug Induced Liver Injury: Highlights and Controversies in the 2023 Literature: Drug-Induced Liver Injury: Highlights and Controversies: H. Singh et al.

Published in:

Drug Safety, 2025, v. 48, n. 5, p. 455, doi. 10.1007/s40264-025-01514-z

By:

Singh, Harjit;
Kunkle, Bryce F.;
Troia, Angela R.;
Suvarnakar, Advait M.;
Waterman, Ade C.;
Khin, Yadana;
Korkmaz, Serena Y.;
O'Connor, Corinne E.;
Lewis, James H.

Publication type:

Article